Bentley adds another Ireland deal

November 23, 2005

NH Business Review Staff,

Bentley Pharmaceuticals made further headway into the Irish market early this week, a move that caused its stock price to jump on Monday.

The Exeter-based drug delivery company’s Irish subsidiary – Bentley Pharmaceuticals Ireland Ltd. — received approval to market generic Omeprazole in Ireland. Omeprazole treats acid-related stomach disorders.

The company’s Spanish subsidiary, Laboratorios Davur, entered into an agreement with the Irish-based Consilient Health Ltd. to distribute the drug throughout the United Kingdom. Laboratorios Belmac SA, another Bentley subsidiary in Spain will manufacture the drug.

On Monday, after the approval was announced, shares gained more than $2 to peak at $17.92 a share. — BOB SANDERS

Categories: News

More news from NHBR:

Take 5: Amazon investments, AI skills and U.S. democracy

NH Business Review's biweekly snapshot of business and industry statistics

Federal regulators visit New Hampshire to encourage brownfields redevelopment

Federal officials visited Manchester this week, aiming to generate excitement about long-running efforts to clean up and redevelop contaminated land.

Pumping up the New Hampshire brand

State teams up with Granite State companies for Made in NH campaign

Pay gaps and workforce dynamics across New Hampshire

Women in New Hampshire are earning less than men and are less likely to be in the workforce, which can have major implications for family finances and the state’s economy.

Q&A with Rob Whitten and Jane Lo, co-founders of p!ng, a robotic coffee shop drive-thru

Rob Whitten and Jane Lo want to speed up that line of cars that snakes around a coffee shop. With P!ng, they’re updating the traditional drive-thru model by replacing human servers with robotic automation and moving orders from speaker boxes to smartphone apps.